Literature DB >> 1585899

Nonparticipation as a determinant of adverse health outcomes in a field trial of oral cholera vaccines.

J D Clemens1, F F van Loon, M Rao, D A Sack, F Ahmed, J Chakraborty, M R Khan, M Yunus, J R Harris, A M Svennerholm.   

Abstract

The authors estimated the incidence rates of cholera and death between 1985 and 1988 for 32,642 age- and sex-eligible persons who did not participate in a randomized, placebo-controlled field trial of killed oral cholera vaccines in rural Bangladesh. As compared with 20,744 placebo recipients, the relative risk of cholera for all nonparticipants, adjusted for potentially confounding demographic variables, was 1.20 (95% confidence interval (CI) 1.03-1.41); this adjusted relative risk reflected elevated adjusted relative risks in nonparticipants who were medically ineligible (RR = 1.65; 95% CI 1.22-2.22) or refused to participate (RR = 1.19; 95% CI 1.01-1.41), but not in persons absent at the time of vaccination (RR = 1.00; 95% CI 0.78-1.28). The adjusted relative risk of death was also elevated in nonparticipants as compared with placebo recipients (RR = 1.28; 95% CI 1.10-1.48), with the same pattern of adjusted relative risks for different categories of nonparticipants: for ineligible subjects, 2.64 (95% CI 2.12-3.29); for refusers, 1.20 (95% CI 1.02-1.41); and for absentees, 0.95 (95% CI 0.75-1.22). The authors concluded that nonparticipation was associated with clinically cogent adverse health outcomes, but that the magnitude of these associations varied according to the reason for nonparticipation. These findings underscore the caution required in assessing vaccine efficacy with controls who are not vaccinated because of choices made by patients or vaccinators.

Entities:  

Keywords:  Asia; Bangladesh; Behavior; Biology; Clinical Research; Clinical Trials; Decision Making; Delivery Of Health Care; Demographic Factors; Developing Countries; Diarrhea; Diseases; Health; Health Services; Human Volunteers; Immunization; Incidence; Measurement; Mortality; Population; Population Dynamics; Primary Health Care; Research Methodology; Risk Factors; Southern Asia; Vaccination--administraction and dosage; Vaccination--beneficial effects

Mesh:

Substances:

Year:  1992        PMID: 1585899     DOI: 10.1093/oxfordjournals.aje.a116382

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

Review 1.  Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis.

Authors:  Natasha Fernandes; Dianne Bryant; Lauren Griffith; Mohamed El-Rabbany; Nisha M Fernandes; Crystal Kean; Jacquelyn Marsh; Siddhi Mathur; Rebecca Moyer; Clare J Reade; John J Riva; Lyndsay Somerville; Neera Bhatnagar
Journal:  CMAJ       Date:  2014-09-29       Impact factor: 8.262

Review 2.  Ethics and research in critical care.

Authors:  Henry J Silverman; Francois Lemaire
Journal:  Intensive Care Med       Date:  2006-08-08       Impact factor: 17.440

3.  Positive Social Impacts Related to Participation in an HIV Prevention Trial Involving People Who Inject Drugs.

Authors:  Jeremy Sugarman; Randy Stalter; Kevin Bokoch; Ting-Yuan Liu; Deborah Donnell
Journal:  IRB       Date:  2015 Jan-Feb

4.  Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

Authors:  Dang Duc Anh; Anna Lena Lopez; Vu Dinh Thiem; Shannon L Grahek; Tran Nhu Duong; Jin Kyung Park; Hye Jung Kwon; Michael Favorov; Nguyen Tran Hien; John D Clemens
Journal:  PLoS Negl Trop Dis       Date:  2011-01-25

5.  Quantifying the Population-Level Effect of the COVID-19 Mass Vaccination Campaign in Israel: A Modeling Study.

Authors:  Ido Somekh; Wasiur R KhudaBukhsh; Elisabeth Dowling Root; Lital Keinan Boker; Grzegorz Rempala; Eric A F Simões; Eli Somekh
Journal:  Open Forum Infect Dis       Date:  2022-02-18       Impact factor: 4.423

Review 6.  Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate.

Authors:  Gunn Elisabeth Vist; Dianne Bryant; Lyndsay Somerville; Trevor Birminghem; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.